The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801

INTRODUCTION: We report the long-term results of RTOG 9801, a randomized trial investigating the ability of amifostine, a radioprotector, to reduce chemoradiation-induced esophagitis. METHODS: Patients with stage II and IIIA/B non-small-cell lung cancer received induction paclitaxel 225 mg/m(2) intr...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Richard, Lawrence Yaacov, Rebecca, Paulus, Corey, Langer, Maria, Werner-Wasik, Buyyounouski Mark, K, Ritsuko, Komaki, Mitchell, Machtay, Colum, Smith, Axelrod Rita, S, Todd, Wasserman, Bradley Jeffrey, D, Benjamin, Movsas
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3646966/
https://ncbi.nlm.nih.gov/pubmed/23477890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2013.02.008
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg